JPMorgan Chase & Co. Announces Benchmark Change to BearLinx Alerian MLP
  Select Index ETN

Business Wire

NEW YORK -- May 06, 2009

JPMorgan Chase & Co. today announced that it has been informed that the
Alerian MLP Select Index, which is the index underlying the BearLinx Alerian
MLP Select Index ETN, will be discontinued by Alerian Capital Management
effective May 15, 2009. Pursuant to the terms of the ETN, J.P. Morgan
Securities Inc., as calculation agent, has determined that effective May 15,
2009 the Alerian MLP Index will be substituted for the Alerian MLP Select
Index for all purposes under the ETNs, including, but not limited to,
determining the payment of any coupons as well as any amounts due at maturity
or upon early redemption. As of May 4, 2009, the Alerian MLP Index had the
same index components as the Alerian MLP Select Index.

JPMorgan Chase & Co.’s other MLP linked ETN, the JPMorgan Alerian MLP Index
ETN, remains unchanged and continues to be linked to the Alerian MLP Index.
This ETN launched in April 2009 and is listed on the NYSE ARCA under ticker
symbol “AMJ”.

The Alerian MLP Index measures the composite performance of energy-oriented
MLPs. MLPs are master limited partnerships primarily engaged in the
exploration, marketing, mining, processing, production, refining, storage or
transportation of any mineral or natural resource.

About JPMorgan Chase & Co.

JPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm
with assets of $2.1 trillion and operations in more than 60 countries. The
firm is a leader in investment banking, financial services for consumers,
small business and commercial banking, financial transaction processing, asset
management and private equity. A component of the Dow Jones Industrial
Average, JPMorgan Chase & Co. serves millions of consumers in the United
States and many of the world’s most prominent corporate, institutional and
government clients under its J.P. Morgan, Chase, and WaMu brands. Information
about JPMorgan Chase & Co. is available at www.jpmorganchase.com.

Investment suitability must be determined individually for each investor, and
the ETNs may not be suitable for all investors. This information is not
intended to provide and should not be relied upon as providing accounting,
legal, regulatory or tax advice.

Investors should consult with their own advisors as to these matters.

JPMorgan Chase & Co. has filed a registration statement (including a
prospectus which contains a product supplement and pricing supplement) with
the Securities and Exchange Commission, or SEC, for the offering to which this
communication relates.

Before you invest, you should read the prospectus in that registration
statement and the other documents relating to this offering that JPMorgan
Chase & Co. has filed with the SEC for more complete information about
JPMorgan Chase & Co. and this offering.

You may get these documents without cost by visiting EDGAR on the SEC website
at www.sec.gov. Alternatively, JPMorganChase & Co., any agent or any dealer
participating in this offering will arrange to send you the prospectus, each
prospectus supplement, product supplement, and the pricing supplement if you
so request by calling toll-free 800-576-3529.

Contact:

JPMorgan Chase & Co.
Tasha Pelio, 212-270-7441
tasha.pelio@jpmorgan.com

Last Updated: May 6, 2009 17:40 EDT